EPOR

protein-coding

erythropoietin receptor, the group of Fibronectin type III domain containing

Gene summary

This gene encodes the erythropoietin receptor which is a member of the cytokine receptor family. Upon erythropoietin binding, this receptor activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated erythropoietin receptor appears to have a role in erythroid cell survival. Defects in the erythropoietin receptor may produce erythroleukemia and familial erythrocytosis. Dysregulation of this gene may affect the growth of certain tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]

MANE transcript

NM_000121.4

Inheritance

AD

ClinVar variants

P:7U:102B:47

Top phenotype

Erythrocytosis, familial, 1

gnomAD constraint

pLI —, LoF o/e 0.35

Max pathogenic AF

—

Genomic locus

chr19:11,377,207-11,384,342

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~7.1 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

primary familial polycythemia due to EPO receptor mutationSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0007572

Submitter: Orphanet

primary familial polycythemia due to EPO receptor mutationSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0007572

Submitter: Genomics England PanelApp

primary familial polycythemia due to EPO receptor mutationSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0007572

Submitter: Labcorp Genetics (formerly Invitae)

primary familial polycythemia due to EPO receptor mutationSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0007572

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Erythrocytosis, familial, 1AD

Manifestation: Hematologic

Intervention: Hematologic

Rationale: Phlebotomy can be used to maintain the hematocrit value in the desired range

Refs: 4052634; 1954391; 093406; 9292543; 9649565; 20700488; 21437635Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to EPOR variants in ClinVar

7 Conditions Cataloged
Inborn genetic diseasesTotal: 65
not providedTotal: 59
Primary familial polycythemia due to EPO receptor mutationTotal: 56
not specifiedTotal: 28
EPOR-related disorderTotal: 8
Intellectual disability-hypotonic facies syndrome, X-linked, 1Total: 1
Acute megakaryoblastic leukemia without down syndromeTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000121.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
7
clinvar
24
clinvar
1
clinvar
32
missense
85
clinvar
18
clinvar
4
clinvar
107
nonsense
2
clinvar
4
clinvar
2
clinvar
8
start loss
0
frameshift
1
clinvar
6
clinvar
7
splice donor/acceptor (+/-2bp)
2
clinvar
2
Total25102425156

Highest pathogenic variant AF is 0.0000780883

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 22 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000121.4RefSeqNP_000112.18MANE Select
ENST00000222139.11EnsemblENSP00000222139.58MANE Select
ENST00000586890.5EnsemblENSP00000467230.14Standard
ENST00000588859.5EnsemblENSP00000466784.14Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
eporDanio rerio

Structure: nucleate erythrocyte

Quality: decreased amount

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • PI3K-Akt signaling pathway - Homo sapiens (human)
  • Jak-STAT signaling pathway - Homo sapiens (human)
  • Pathways in cancer - Homo sapiens (human)
  • Hematopoietic cell lineage - Homo sapiens (human)
  • Cytokine-cytokine receptor interaction - Homo sapiens (human)

Biological Process

  • signal transduction
  • brain development
  • heart development
  • positive regulation of phosphatidylinositol 3-kinase signaling
  • erythropoietin-mediated signaling pathway

Molecular Function

  • erythropoietin receptor activity
  • protein binding
  • identical protein binding

Cellular Component

  • extracellular region
  • plasma membrane
  • integral component of plasma membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000222139
Coding exons
8
Length
6783
Individuals with no LoFs
125710
Homozygous LoFs
0
Heterozygous LoFs
36
Defined
125746
p
0.000143
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.142382930.8130.00001433209
Missense (PolyPhen)5587.4720.628771050
Synonymous-0.2621361321.030.000006631097
Loss of Function2.72720.20.3478.72e-7219

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000770.000062rare
Latino/Admixed American0.000420.00040rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.0000470.000046rare
European (Non-Finnish)0.000140.00014rare
South Asian0.0000980.000098rare
Other0.000180.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Receptor for erythropoietin. Mediates erythropoietin- induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase.;
Disease
DISEASE: Erythrocytosis, familial, 1 (ECYT1) [MIM:133100]: An autosomal dominant disorder characterized by increased serum red blood cell mass, elevated hemoglobin and hematocrit, hypersensitivity of erythroid progenitors to erythropoietin, erythropoietin low serum levels, and no increase in platelets nor leukocytes. It has a relatively benign course and does not progress to leukemia. {ECO:0000269|PubMed:8506290, ECO:0000269|PubMed:8608241}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

LoFtool
0.238
RVIS EVS
0.78
RVIS percentile EVS
87.14

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.949

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.